A second coronavirus vaccine manufacturer has warned of supply issues to the European Union, compounding frustration in the bloc. AstraZeneca said a production problem meant the number of initial doses available would be lower than expected. The fresh blow comes after some nations' inoculation programmes were slowed due to a cut in deliveries of the Pfizer-BioNTech vaccine. The drug firm had been set to deliver about 80 million doses to the 27 nations by March, according to the official who spoke to Reuters. The AstraZeneca vaccine, developed with Oxford University, has not yet been approved by the EU's drug regulator but is expected to get the green light at the end of this month, paving the way for jabs to be given. We insisted on a precise delivery schedule on the basis of which Member States should be planning their vaccination programs, subject to the granting of a contitional marketing authorisation. A spokesman for AstraZeneca said on Friday that "initial volumes will be lower than originally anticipated" without giving further details.
Top suggestions for crossdressing teens. CD Crossdress. Boy to Girl Dress.
The Senate rejects arguments from Trump's defence he should not face trial as he has left office. The woman was reportedly shot in the head by police at a rally in the capital Nay Pyi Taw on Tuesday. Sima Kotecha follows the origins of a "dangerous" viral video about a false Covid treatment.